The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Study of AS1411 in Advanced Solid Tumours
Official Title: Phase I Open Label Study of AS1411 in Advanced Solid Tumours
Study ID: NCT00881244
Brief Summary: A Phase I open label study of AS1411 in advanced solid tumours. Objectives include determining the MTD and DLT of AS1411, to determine the PK profile of AS1411 and to obtain preliminary evidence of clinical and biological responses to AS1411 therapy.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky, United States